Skip to content
WHO advisory committee recommends expanding use of Pfizer vaccine to ages 5-11 By Reuters
 |  Latest News Headlines

WHO advisory committee recommends expanding use of Pfizer vaccine to ages 5-11 By Reuters
| Today Headlines | Local News


2/2

© Reuters. FILE PHOTO: Doses of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine for children are prepared at a children’s medical office in Maintal near Frankfurt, Germany December 15, 2021. REUTERS/Kai Pfaffenbach

2/2

(Reuters) – The World Health Organization’s advisory group on Friday recommended expanding the use of a reduced dose of Pfizer (NYSE 🙂 and German partner BioNTech’s COVID-19 vaccine for children aged 5-11.

The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunization held a meeting on Wednesday to assess the companies’ vaccine. The vaccine is currently recommended for use in people aged 12 and over.

The recommended dosage for the younger population is 10 micrograms instead of the 30 micrograms offered for ages 12 and older.

“This age group (5-11 years) is among the lowest priority use group for vaccination, with the exception of children who have comorbidities,” said SAGE President Alejandro Cravioto.

The committee also recommended that booster doses of the COVID-19 vaccine be given 4 to 6 months after the end of the primary series, in high priority groups like the elderly and health workers.

Source

WHO advisory committee recommends expanding use of Pfizer vaccine to ages 5-11 By Reuters
| Breaking News Updates Fox news

zimonewszimonews Trans